Company facts
- Headquarters
- Dallas, Texas
- Most recent report
- 8-K, filed Oct 9, 2026
- Incorporated
- Texas
- Filings on record
- 240 filings
- On EDGAR
- CIK 1938046
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 15
News 8 of 78
- 8-K Significant contract Oct 9, 2026
- 8-K Significant contract Oct 1, 2026
- 8-K Current report on a material event Aug 21, 2026
- 8-K Other events Aug 4, 2026
- 8-K Leadership change Jul 30, 2026
- 8-K Significant contract Jul 2, 2026
- 8-K Leadership change Mar 17, 2026
- 8-K Current report on a material event Feb 23, 2026
Prospectuses and Registrations 8 of 27
- 424B5 Prospectus supplement for an offering Oct 9, 2026
- S-8 Registration statement for an employee plan Jul 10, 2026
- S-1/A Registration statement for an offering, amended Jan 23, 2026
- S-1 Registration statement for an offering Jan 13, 2026
- 424B5 Prospectus supplement for an offering Dec 19, 2025
- S-3 Shelf registration statement Jun 13, 2025
- S-1 Registration statement for an offering May 30, 2025
- S-8 Registration statement for an employee plan Apr 1, 2025
Proxies 6
- DEF 14A Proxy statement for a shareholder vote Feb 18, 2025
- PRE 14A Preliminary proxy statement Feb 6, 2025
- DEF 14A Proxy statement for a shareholder vote May 16, 2024
- PRE 14A Preliminary proxy statement May 6, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 1, 2024
- PRE 14A Preliminary proxy statement Feb 20, 2024
Ownership 8 of 53
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Oct 6, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Mar 20, 2026
- 4 Insider reported a trade Dec 17, 2025
- 4 Insider reported a trade Dec 11, 2025
Other 8 of 61
Everything here comes from Mangoceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.